sophie laurent
sophie laurent
Verified email at
Cited by
Cited by
Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications
S Laurent, D Forge, M Port, A Roch, C Robic, L Vander Elst, RN Muller
Chemical reviews 108 (6), 2064-2110, 2008
Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
M Mahmoudi, S Sant, B Wang, S Laurent, T Sen
Advanced drug delivery reviews 63 (1-2), 24-46, 2011
Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles
S Laurent, S Dutz, UO Häfeli, M Mahmoudi
Advances in colloid and interface science 166 (1-2), 8-23, 2011
Toxicity of nanomaterials
S Sharifi, S Behzadi, S Laurent, ML Forrest, P Stroeve, M Mahmoudi
Chemical Society Reviews 41 (6), 2323-2343, 2012
Protein− nanoparticle interactions: opportunities and challenges
M Mahmoudi, I Lynch, MR Ejtehadi, MP Monopoli, FB Bombelli, S Laurent
Chemical reviews 111 (9), 5610-5637, 2011
Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging
JL Bridot, AC Faure, S Laurent, C Riviere, C Billotey, B Hiba, M Janier, ...
Journal of the American Chemical Society 129 (16), 5076-5084, 2007
Graphene: promises, facts, opportunities, and challenges in nanomedicine
HY Mao, S Laurent, W Chen, O Akhavan, M Imani, AA Ashkarran, ...
Chemical reviews 113 (5), 3407-3424, 2013
Classification and basic properties of contrast agents for magnetic resonance imaging
CFGC Geraldes, S Laurent
Contrast media & molecular imaging 4 (1), 1-23, 2009
Nanoadsorbents: classification, preparation, and applications (with emphasis on aqueous media)
M Khajeh, S Laurent, K Dastafkan
Chemical reviews 113 (10), 7728-7768, 2013
Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents
S Laurent, LV Elst, RN Muller
Contrast media & molecular imaging 1 (3), 128-137, 2006
Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges
S Laurent, AA Saei, S Behzadi, A Panahifar, M Mahmoudi
Expert opinion on drug delivery 11 (9), 1449-1470, 2014
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
T Vangijzegem, D Stanicki, S Laurent
Expert opinion on drug delivery 16 (1), 69-78, 2019
Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine
M Mahmoudi, H Hosseinkhani, M Hosseinkhani, S Boutry, A Simchi, ...
Chemical reviews 111 (2), 253-280, 2011
Effect of nanoparticles on the cell life cycle
M Mahmoudi, K Azadmanesh, MA Shokrgozar, WS Journeay, S Laurent
Chemical reviews 111 (5), 3407-3432, 2011
Toxicity Evaluations of Superparamagnetic Iron Oxide Nanoparticles: Cell “Vision” versus Physicochemical Properties of Nanoparticles
M Mahmoudi, S Laurent, MA Shokrgozar, M Hosseinkhani
ACS nano 5 (9), 7263-7276, 2011
Heterocyst differentiation and pattern formation in cyanobacteria: a chorus of signals
CC Zhang, S Laurent, S Sakr, L Peng, S Bédu
Molecular microbiology 59 (2), 367-375, 2006
Personalized protein coronas: a “key” factor at the nanobiointerface
MJ Hajipour, S Laurent, A Aghaie, F Rezaee, M Mahmoudi
Biomaterials science 2 (9), 1210-1221, 2014
A high-performance magnetic resonance imaging T2 contrast agent
J Qin, S Laurent, YS Jo, A Roch, M Mikhaylova, ZM Bhujwalla, RN Muller, ...
Advanced Materials 19 (14), 1874-1878, 2007
Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment
S Laurent, L Vander Elst, F Copoix, RN Muller
Investigative radiology 36 (2), 115-122, 2001
Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer
S Laurent, M Mahmoudi
International journal of molecular epidemiology and genetics 2 (4), 367, 2011
The system can't perform the operation now. Try again later.
Articles 1–20